Geneticist Sidi Chen Receives Large Award Which Will Further His Breast Cancer Work
This Department of Defense award goes to the “best and brightest in their fields,” and recognizes “creative and innovative individuals.” Investigators are chosen for their ability “to go beyond conventional thinking” in their respective areas of expertise.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Yale researchers focus on new cancer treatments
October is Breast Cancer Awareness Month, and at Yale University researchers have been working on a potentially new and effective way to fight cancer. “We don't know what starts it. It could be the food, it could be the water, it could be genetic,” said Tarek Fahmy, an associate professor of biomedical engineering at Yale University.Source: WFSB
Women's Health Research at Yale: 2013 Pilot Project Awards Announced
This year’s content areas include breast cancer, the second leading cause of cancer deaths in women; autoimmune diseases, more common in women than men, including antiphospholipid syndrome, (or APS), which can cause stroke, heart attack and pregnancy-related problems, and lupus; HIV prevention, as HIV is far more prevalent among young black women than other young women, and sexually transmitted infections that affect more women than men and currently have no cure or intervention to prevent recur
Study: Breast Cancer Screening May Not Be as Helpful for Older Women
Breast cancer screenings past the age of 70 may be unnecessary—and even harmful—for some women, a new study suggests.1 The research, published earlier this month in the Annals of Internal Medicine, raises questions about the risks of overdiagnosis and the efficacy of blanket recommendations that apply to all women in this age group. “A key message from our research is: There’s no one-size-fits-all solution for older women,” Ilana Richman, MD, MHS, an internal medicine specialist and assistant professor at Yale School of Medicine, and the first author of the new study, told Health.Source: Health
Screening Mammograms Carry Risks for Older Women, Study Finds
Although some guidelines recommend continuing screening for older women, this new study emphasizes the importance of assessing potential harms associated with testing, such as overdiagnosis, which, researchers say, can negatively affect quality of life.
Breast Cancer Research Breakthroughs Signal Paradigm Shifts Across Disease Subsets
Maryam Lustberg, MD, MPH, discusses insights regarding other key breast cancer data presented at the 2023 ASCO Annual Meeting, including findings from the phase 3 BWEL trial, updated data from the phase 2 ELAINE-2 trial, and the final overall survival analysis of the phase 3 TROPiCS-02 trial.Source: OncLive
Survivors, Learn Your Risk of Breast Cancer Recurrence (And How to Reduce It)
If you’ve had breast cancer, you know the battle isn’t over when your initial treatment is finished. According to Tara Sanft, MD, a breast oncologist and chief patient experience officer at Yale’s Smilow Cancer Hospital, one in eight women will develop breast cancer in their lives. Unfortunately, even after that initial diagnosis and treatment, there’s a six percent chance of a breast cancer recurrence within the first five years, which means cancer can come back or spread to other parts of the body. But cancer isn’t just a five-year battle — in fact, half of recurrences in women with hormone receptor-positive (HR+) breast cancer happen after five years. “A hallmark of hormone receptor-positive cancer,” says Dr. Sanft, “is that a recurrence can happen decades out.”Source: Katie Couric Media
Breaking Down Barriers in Breast Cancer Care
A breast cancer diagnosis can be devastating in any language – but what if you don’t speak or understand the language? At Bridgeport Hospital, a new Hispanic Breast Cancer Program is breaking new ground while breaking down communication and cultural barriers to better meet the needs of a growing Hispanic population.
Don’t take away critical surgery options from breast cancer patients
DIEP (deep inferior epigastric perforator), in which abdominal tissue is transplanted to the chest without using abdominal muscle, may soon be less available. Why? The Centers for Medicare and Medicaid Services (CMS) is planning to eliminate the billing codes for this and other specialized breast reconstruction procedures on Dec. 31, 2024. This should not be the case: women facing breast cancer need all the best reconstruction options readily available. This is deeply personal for me.Source: The Hill
CDK4/6 Inhibitors in Breast Cancer: New Populations, Different Settings
At the American Society of Clinical Oncologyopens in a new tab or window (ASCO) annual meeting, a poster discussion session on metastatic breast cancer entitled "CDK4/6 Inhibitors: New Populations, Different Settings" was presented by Maryam Lustberg, MD, MPH opens in a new tab or window, the chief of breast oncology at the Yale Cancer Center in New Haven, Connecticut. She discussed the results from three posters -- the LEONARDA-1 studyopens in a new tab or window, the PALOMAGE programopens in a new tab or window, and the AURORA Molecular Screening Initiativeopens in a new tab or window.Source: MedPage Today
Don’t Let Breast Cancer Subtype Guide Mastectomy Choice, Doctors Say
The decision to have mastectomy is “complex and layered,” says Mehra Golshan, MD, clinical director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center. It requires a shared decision-making between the patient and the provider, says Golshan, who wasn’t involved in the study. “There are some women who absolutely have to have mastectomy. However, most are eligible for either surgery,” Golshan says.Source: WebMD